PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study
Public ClinicalTrials.gov record NCT02250313. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main hypothesis of this study is to demonstrate that the use of the ConfirmMDx for Prostate Cancer test in previously biopsied patients improves urologists' patient management by reducing unnecessary repeat biopsies, attendant procedure costs, and potential adverse events in men being considered for a repeat procedure.
Study identification
- NCT ID
- NCT02250313
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 40 Years to 75 Years
- Sex
- Male
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2014
- Primary completion
- Jun 30, 2018
- Completion
- Jun 30, 2018
- Last update posted
- Jul 25, 2018
2014 – 2018
United States locations
- U.S. sites
- 15
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urology Centers of Alabama | Homewood | Alabama | 35209 | — |
| Genesis Research LLC | San Diego | California | 92123 | — |
| Skyline Urology | Torrance | California | 90505 | — |
| Urology Center of Colorado | Denver | Colorado | 80211 | — |
| First Urology, PSC | Jeffersonville | Indiana | 47130 | — |
| Regional Urology, LLC | Shreveport | Louisiana | 71106 | — |
| Chesapeake Urology Research Associates | Towson | Maryland | 21204 | — |
| Michigan Institute of Urology | Troy | Michigan | 48084 | — |
| Associated Medical Professionals of NY | Syracuse | New York | 13210 | — |
| Oregon Urology Institute | Springfield | Oregon | 97477 | — |
| Lancaster Urology | Lancaster | Pennsylvania | 17604 | — |
| Carolina Urological Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Urology Associates, P.C. | Nashville | Tennessee | 37209 | — |
| Urology Clinics of North Texas, PLLC | Dallas | Texas | 75231 | — |
| Urology San Antonio Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02250313, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 25, 2018 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02250313 live on ClinicalTrials.gov.